27 articles for Z Wei
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
4
Synthesis and biological evaluation of novel pyrazoline derivatives as potent anti-inflammatory agents.
Sichuan University
6
New efficient imidazolium aldoxime reactivators for nerve agent-inhibited acetylcholinesterase.
Institute of Pharmacology and Toxicology
38
Discovery of agonists of cannabinoid receptor 1 with restricted central nervous system penetration aimed for treatment of gastroesophageal reflux disease.
AstraZeneca
16
Synthesis and biological evaluation of 4'-[(benzimidazole-1-yl)methyl]biphenyl-2-sulfonamide derivatives as dual angiotensin II/endothelin A receptor antagonists.
China Pharmaceutical University
25
N-Methyl-3-(tetrahydro-2H-pyran-4-yl)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamides as a novel class of cannabinoid receptors agonists with low CNS penetration.
AstraZeneca
27
Discovery of Isobenzofuran-1(3H)-one Derivatives as Selective TREK-1 Inhibitors with In Vitro and In Vivo Neuroprotective Effects.
Chinese Academy of Medical Sciences and Peking Union Medical College
1
Discovery of a potent and in vivo anti-inflammatory Efficacious, P2Y14R antagonist with a novel benzisoxazoles scaffold by DNA-encoded chemical library technology.
Zhengzhou University
1
Discovery of a potent, Highly selective, and In vivo anti-inflammatory Efficacious, P2Y6R antagonist with a novel quinoline-pyrazole scaffold.
Zhengzhou University
15
Discovery of Novel, Potent, Orally Bioavailable and Efficacious, Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Hematopoietic Stem Cell Mobilization.
FibroGen Inc.
13
Screening of efficient salicylaldoxime reactivators for DFP and paraoxon-inhibited acetylcholinesterase.
Air Force Medical University
13
Synthesis and biological activity of 2-alkylbenzimidazoles bearing a N-phenylpyrrole moiety as novel angiotensin II AT1 receptor antagonists.
China Pharmaceutical University
23
Discovery of the First Potent IDO1/IDO2 Dual Inhibitors: A Promising Strategy for Cancer Immunotherapy.
China Pharmaceutical University
20
Molecular modeling-guided optimization of acetylcholinesterase reactivators: A proof for reactivation of covalently inhibited targets.
Fourth Military Medical University
49
Discovery of MK-8719, a Potent O-GlcNAcase Inhibitor as a Potential Treatment for Tauopathies.
Merck
22
Study of triaryl-based sulfamic acid derivatives as HPTPβ inhibitors.
National Engineering Research Center For The Emergency Strategic Drug
31
Conjugates of salicylaldoximes and peripheral site ligands: Novel efficient nonquaternary reactivators for nerve agent-inhibited acetylcholinesterase.
Fourth Military Medical University
3
Isoxazolo-quinazolines as modulators of protein kinase activity
Nerviano Medical Sciences
16
2-aminoquinoline-based compounds for potent and selective neuronal nitric oxide synthase inhibition
Northwestern University
40
Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitors
Bayer Intellectual Property
16
Methods for increasing the stabilization of hypoxia inducible factor-1 alpha
Aerpio Therapeutics
37
Anti-infective agents against intracellular pathogens
The Ohio State University Research Foundation
9
Cloning and expression of a 5-hydroxytryptamine7 receptor positively coupled to adenylyl cyclase.
Syntex Discovery Research
22
Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain.
Novo Industri